SynthesisBMJ open2019

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review.

Karin Luttropp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.